Welcome Dino Sirianni to #NSPharma as our new Key Account Manager!
He brings extensive experience from Amneal Biosciences, American Regent, Pfizer and EKR Therapeutics. In his spare time, he enjoys golf and family time.
#EGPA is a rare immune disease that often starts with asthma and allergies. Current treatments rely on steroids, but #NSPharma is developing NS-229, a more targeted therapy now in clinical trials with FDA Orphan Drug status.
Say hello to Kellie Drangeid, our newest Area Business Manager!
With 20+ years in strategic account management, reimbursement and field leadership across neurology, immunology and rare disease, she brings incredible expertise to the #NSPharma team!
💙 Welcome Laurian Sequeira to #NSPharma as Area Business Manager!
With 20+ years in strategic account management, sales excellence & product launches across neurology, genetics, and oncology, she brings expertise and passion to our team. We’re thrilled to have you!